Chan et al have shown that in the Taiwanese population, IRS2 Gly1057 homozygous/heterozygous individuals are at increased risk of developing CAD, whereas Asp/Asp1057 individuals are protected against CAD [24]. The gene discussed is IRS2; the disease is coronary artery disorder.